Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2015 1
2016 2
2017 1
2019 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study.
Pfützner A, Hanna M, Andor Y, Sachsenheimer D, Demircik F, Wittig T, de Faire J. Pfützner A, et al. Among authors: sachsenheimer d. Nutr Metab Insights. 2022 Jun 23;15:11786388221108919. doi: 10.1177/11786388221108919. eCollection 2022. Nutr Metab Insights. 2022. PMID: 35769391 Free PMC article.
Impact of a Single Dose of a Probiotic Nutritional Supplement (AB001) on Absorption of Ethylalcohol: Results From a Randomized Double-Blind Crossover Study.
Pfützner A, Pfützner A, Hanna M, Demircik F, Sachsenheimer D, Wittig T, de Faire J. Pfützner A, et al. Among authors: sachsenheimer d. Nutr Metab Insights. 2023 Jan 15;16:11786388221141174. doi: 10.1177/11786388221141174. eCollection 2023. Nutr Metab Insights. 2023. PMID: 36686368 Free PMC article.
Clinical assessment of the accuracy of blood glucose measurement devices.
Pfützner A, Mitri M, Musholt PB, Sachsenheimer D, Borchert M, Yap A, Forst T. Pfützner A, et al. Among authors: sachsenheimer d. Curr Med Res Opin. 2012 Apr;28(4):525-31. doi: 10.1185/03007995.2012.673479. Epub 2012 Mar 21. Curr Med Res Opin. 2012. PMID: 22435798 Clinical Trial.
Longer Usage Time for CSII Catheters: An Underestimated Challenge.
Pfützner A, Sachsenheimer D, Grenningloh M. Pfützner A, et al. Among authors: sachsenheimer d. J Diabetes Sci Technol. 2016 Jun 28;10(4):987-8. doi: 10.1177/1932296815626727. Print 2016 Jul. J Diabetes Sci Technol. 2016. PMID: 26856627 Free PMC article. No abstract available.
Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
Pfützner A, Sachsenheimer D, Grenningloh M, Heschel M, Walther-Johannesen L, Gharabli R, Klonoff D. Pfützner A, et al. Among authors: sachsenheimer d. J Diabetes Sci Technol. 2015 Sep 3;9(6):1292-8. doi: 10.1177/1932296815604438. J Diabetes Sci Technol. 2015. PMID: 26341262 Free PMC article. Clinical Trial.
Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
Tadić A, Gorbulev S, Dahmen N, Hiemke C, Braus DF, Röschke J, van Calker D, Wachtlin D, Kronfeld K, Gorbauch T, Seibert-Grafe M, Lieb K; EMC Study Group. Tadić A, et al. Trials. 2010 Feb 26;11:21. doi: 10.1186/1745-6215-11-21. Trials. 2010. PMID: 20187947 Free PMC article. Clinical Trial.